Best deals to access real time data! |
|
SMALL CAP PRO
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
ULTIMATE TRADER
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Revance Therapeutics, Inc. (MM) | RVNC | NASDAQ | Common Stock | US7613301099 |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| +0.05 | +0.21% | 23.8 | 24.1 | 23.35 | 23.65 | 23.75 | 13:08:41 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 23.8 | 23.85 | 0.05 | 0.21% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 559 | 67,417 | $ 23.6083 | $ 1.59M | 188.57k | 12.35 - 28.30 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:08:39 | 100 | $23.80 | USD |
Revance Therapeutics, Inc. (MM) Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 733.5M | 30.82M | $ -89.27M | -3.18 | 0.00 | 10.08M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 0.00 | 0.00% | 22.11k | 99.50% |
Revance Therapeutics, Inc. (MM) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 8/04/2017 | 17:10 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 8/03/2017 | 16:14 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 8/03/2017 | 16:05 | Business Wire | Revance Releases Second Quarter 2017 Results |
| 8/02/2017 | 17:06 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 8/01/2017 | 16:05 | Business Wire | Revance Therapeutics Expands Leadership Team, Appointing.. |
| 7/24/2017 | 16:05 | Business Wire | Revance Therapeutics to Release Second Quarter 2017.. |
| 6/15/2017 | 08:00 | Business Wire | Positive BELMONT Phase 2 Trial Results Published in.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RVNC Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 22.6 | 24.1 | 22.35 | 23.2678 | 81k | 162k | 132k | 1.2 | 5.31% |
| 1 Month | 22.75 | 25.1 | 22.05 | 23.2847 | 77k | 433k | 156k | 1.05 | 4.62% |
| 3 Months | 20.55 | 28.3 | 20.2084 | 24.1782 | 77k | 514k | 204k | 3.25 | 15.82% |
| 6 Months | 21.25 | 28.3 | 18 | 22.3254 | 49k | 793k | 189k | 2.55 | 12.00% |
| 1 Year | 14.81 | 28.3 | 12.35 | 19.9934 | 49k | 963k | 180k | 8.99 | 60.70% |
| 3 Years | 24.54 | 42.45 | 12.35 | 22.8878 | 0 | 4M | 222k | -0.74 | -3.02% |
| 5 Years | 21 | 42.45 | 12.35 | 24.0130 | 0 | 5M | 224k | 2.8 | 13.33% |
